The revenue beat on the back of the CAC Group acquisition and in-line adjusted EPS may support the stock near term, but persistently low organic growth (2%) and GAAP losses could weigh on sentiment. Monitor upcoming quarters for organic growth acceleration—management targets a double-digit run rate exiting 2026. The $250M buyback authorization provides downside support.
Price Chart
Executive Summary
Baldwin Insurance Group reported Q1 2026 total revenue of $532.2M (+29% YoY, beating consensus of $523.8M), but organic revenue growth slowed to 2%. Adjusted diluted EPS of $0.63 matched consensus exactly, though GAAP diluted EPS was only $0.02 due to acquisition-related charges. Adjusted EBITDA grew 21% to $137.2M, yet margins contracted to 25.8% from 27.5% a year ago. No formal guidance was provided, but management expressed confidence in accelerating organic growth through the year. The mixed quarter—strong acquisition-driven top-line growth offset by weak organic trends and GAAP losses—suggests a neutral-to-moderate near-term reaction.
Key Financial Metrics
Key Facts
- Total revenue $532.2M vs consensus $523.8M (beat by 1.6%)
- Organic revenue growth only 2% YoY (vs 10% in Q1 2025)
- Adjusted diluted EPS $0.63, in line with consensus, down 3% YoY
- Adjusted EBITDA grew 21% to $137.2M, but margin declined to 25.8% from 27.5%
- GAAP net loss of $1.9M vs prior-year net income of $24.9M, driven by acquisition costs and higher amortization
- CAC Group integration ahead of plan with ~80% of three-year expense synergies actioned
- Cash and equivalents $146M; $393M revolver capacity; $46.97M in share repurchases during Q1
- No quantitative forward guidance provided
Financial Impact
Revenue beat consensus by ~$8.4M; adjusted EPS exactly in line; GAAP net loss widened significantly due to acquisition accounting
Risk Factors
- Organic growth deceleration could signal market share challenges or integration friction
- Elevated debt from acquisitions (total debt ~$2.35B) increases financial leverage
- GAAP losses and negative free cash flow strain balance sheet flexibility
- Failure to achieve targeted cost synergies or organic re-acceleration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001781755-26-000032 |
| Document: bwin-20260504.htm | 0001781755-26-000032 |
| Document: 0001781755-26-000032-index-headers.html | 0001781755-26-000032 |
| Document: 0001781755-26-000032-index.html | 0001781755-26-000032 |
| Document: 0001781755-26-000032.txt | 0001781755-26-000032 |
| 8-K Data (Synthetic) | 0001781755-26-000032 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $31.91 | awaiting T+1 | awaiting T+1 | $31.91 (−0.00%) |
Oct 15, 2026 12d ago | SC 13E-3 | $31.93 $31.91 | ▼ −0.06% | ▲ +1.04% | $31.91 (−0.06%) |
Oct 15, 2026 12d ago | PREM14A | $31.93 $31.91 | ▼ −0.06% | ▲ +1.04% | $31.91 (−0.06%) |
Oct 7, 2026 20d ago | SC 13G/A | $31.81 $31.85 | ▲ +0.13% | ▲ +0.55% | $31.91 (+0.31%) |
Sep 25, 2026 4w ago | SC 13G | $31.82 $31.78 | ▼ −0.13% | ▲ +0.06% | $31.91 (+0.28%) |
Sep 21, 2026 5w ago | 8-K | $31.89 $31.95 | ▲ +0.19% | ▲ +0.20% | $31.91 (+0.06%) |
Sep 14, 2026 6w ago | DEFA14A | $32.49 $32.04 | ▼ −1.39% | ▼ −0.94% | $31.91 (−1.79%) |
Sep 14, 2026 6w ago | DEFA14A | $32.49 $32.04 | ▼ −1.39% | ▼ −0.94% | $31.91 (−1.79%) |
Sep 14, 2026 6w ago | 8-K | $32.00 $32.49 | ▲ +1.53% | ▲ +1.99% | $31.91 (−0.28%) |
Jun 4, 2026 20w ago | 8-K | $19.88 $19.24 | ▼ −3.22% | ▼ −3.45% | $31.91 (+60.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers